MRSO

MRSO FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of MRSO (5619.T) as of Oct 18, 2026 is 111.22 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -76.85 % — a change of -244.72% (higher).

FCF Conversion

111.22 %

YoY

-244.72%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of MRSO is 2025 111.22 % . FCF Conversion Rate (FCF/EBITDA) of MRSO was 2024 -76.85 % . It decreases by -244.72% higher compared to the previous year.

The MRSO FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2021
168.82 JPY
Jan 1, 2022
106.30 JPY
Jan 1, 2023
11.11 JPY
Jan 1, 2024
-76.85 JPY
Jan 1, 2025
111.22 JPY
The MRSO FCF Conversion history
YEARFCF ConversionYoY
111.22 %-244.72%
-76.85 %-791.70%
11.11 %-89.55%
106.30 %-37.03%
168.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MRSO Stock analysis

What does MRSO do? MRSO Inc is a Japanese technology company headquartered in Minato-ku, Tokyo, specializing in healthcare digital transformation. Listed on the Tokyo Stock Exchange under the ticker 5619.T with ISIN JP3860180003, the firm went public on December 21, 2023. The company employs a small, focused team of twenty full-time staff members dedicated to enhancing operational efficiency and marketing activities within the healthcare sector. MRSO’s core business revolves around providing comprehensive solutions that streamline medical checkups and vaccination processes for various stakeholders, including medical facilities, government bodies, and individual patients. The company’s service portfolio is divided into three primary segments: Healthcare Platform, Digital Transformation services, and large-scale vaccination support. The Healthcare Platform segment operates MRSO.jp, a centralized reservation platform designed to facilitate appointments for medical and health checkups. This service aims to reduce administrative burdens on healthcare providers while improving accessibility for patients seeking routine screenings. In the Digital Transformation space, MRSO offers tailored solutions for both medical institutions and government entities. For medical facilities, the company provides MRSO-Plus, a cloud-based reservation management system that optimizes scheduling and patient flow. For government agencies, MRSO delivers specialized reservation systems such as MRSO Jumin Kenshin, MRSO Vaccine, MRSO Form, and MRSO Go Yoyaku. These tools are engineered to handle high-volume public health initiatives, ensuring efficient data management and appointment coordination. Additionally, MRSO provides large-scale vaccination services, which include an online reservation system designed to manage mass immunization campaigns. This system allows for streamlined registration and scheduling, critical during public health emergencies or seasonal flu drives. By integrating digital tools with healthcare operations, MRSO helps clients improve their service delivery and resource allocation. The company’s approach emphasizes the use of technology to solve logistical challenges in healthcare, particularly in the areas of preventive medicine and public health administration. As a relatively new public entity, MRSO Inc represents a niche player in the Japanese market, focusing on the intersection of healthcare services and digital innovation. Its recent IPO marks a significant step in its growth trajectory, providing capital to further develop its platform technologies and expand its service offerings. The company’s website, https://www.mrso.co.jp/, serves as the primary hub for information regarding its services and corporate updates. Through its specialized focus on medical checkup reservations and vaccination logistics, MRSO Inc positions itself as a key enabler of modernized healthcare infrastructure in Japan. MRSO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MRSO stock

FCF Conversion Rate (FCF/EBITDA) of MRSO is 111.22 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of MRSO changed from -76.85 % to 111.22 %, representing a -244.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) MRSO since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s MRSO with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — MRSO

All Key Metrics — MRSO